{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:36:44Z","timestamp":1782322604292,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00415-020-10300-z","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T17:02:46Z","timestamp":1605286966000},"page":"1419-1433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-8578","authenticated-orcid":false,"given":"Manjunath","family":"Netravathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram Venkappayya","family":"Holla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atchayaram","family":"Nalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seena","family":"Vengalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Thomas","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultana Shaik","family":"Reshma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Treesa","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhat","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"10300_CR1","first-page":"174","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas Lowy D, Musallam A et al (2016) Clinical and MRI phenotype of children with MOG antibodies. MultScler 22:174\u2013184","journal-title":"MultScler"},{"issue":"1","key":"10300_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","volume":"77","author":"P Waters","year":"2019","unstructured":"Waters P, Fadda G, Woodhall M, O\u2019Mahony J, Brown RA, Castro DA et al (2019) Serial anti\u00admyelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol 77(1):82\u201393. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2940","journal-title":"JAMA Neurol"},{"key":"10300_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:134. https:\/\/doi.org\/10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10300_CR4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","volume":"266","author":"R Wynford-Thomas","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V (2019) Neurological update: MOG-antibody disease. J Neurol 266(5):1280\u20131286. https:\/\/doi.org\/10.1007\/s00415-018-9122-2","journal-title":"J Neurol"},{"issue":"3","key":"10300_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","volume":"19","author":"T Armangue","year":"2020","unstructured":"Armangue T, Olive-Cirera G, Martinez-Hernadez E, Sepulveda M, Ruiz-Garcia R, Munoz-Batista M et al (2020) Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 19(3):234\u2013246. https:\/\/doi.org\/10.1016\/S1474-4422(19)30488-0","journal-title":"Lancet Neurol"},{"key":"10300_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","volume":"89","author":"EM Hennes","year":"2017","unstructured":"Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A et al (2017) Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 89:900\u2013908. https:\/\/doi.org\/10.1212\/WNL.0000000000004312","journal-title":"Neurology"},{"key":"10300_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1352458512470310","volume":"19","author":"K Rost\u00e1sy","year":"2013","unstructured":"Rost\u00e1sy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A et al (2013) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin\u00ad4 antibody negative pediatric neuromyelitis optica. MultScler 19:1052\u20131059. https:\/\/doi.org\/10.1177\/1352458512470310","journal-title":"MultScler"},{"key":"10300_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Victor Fung SC et al (2018) Clinical course, therapeutic responses and outcomes in relapsing MOG antibody\u00adassociated demyelination. J NeurolNeurosurg Psychiatry 89:127\u2013137. https:\/\/doi.org\/10.1136\/jnnp-2017-316880","journal-title":"J NeurolNeurosurg Psychiatry"},{"key":"10300_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B et al (2018) Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody\u00adassociated disease. JAMA Neurol 75:478\u2013487. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4601","journal-title":"JAMA Neurol"},{"key":"10300_CR10","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/1352458516631038","volume":"22","author":"M Baumann","year":"2016","unstructured":"Baumann M, Hennes E-M, Schanda K, Karenfort M, Kornek B, Seidl R et al (2016) Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. MultScler 22:1821\u20131829. https:\/\/doi.org\/10.1177\/1352458516631038","journal-title":"MultScler"},{"key":"10300_CR11","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00415-020-09869-2","volume":"267","author":"J Ding","year":"2020","unstructured":"Ding J, Ren K, Wu J, Li H, Sun T, Yan Y, Guo J (2020) Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy. J Neurol 267:2589\u20132593. https:\/\/doi.org\/10.1007\/s00415-020-09869-2","journal-title":"J Neurol"},{"key":"10300_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","volume":"264","author":"\u00c1 Cobo-Calvo","year":"2017","unstructured":"Cobo-Calvo \u00c1, Ruiz A, D\u2019Indy H, Anne-Lisa P, Carneiro M, Philippe N et al (2017) MOG antibody-related disorders: common features and uncommon presentations. J Neurol 264:1945\u20131955. https:\/\/doi.org\/10.1007\/s00415-017-8583-z","journal-title":"J Neurol"},{"issue":"2","key":"10300_CR13","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","volume":"4","author":"O Ryo","year":"2017","unstructured":"Ryo O, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. NeurolNeuroimmunolNeuroinflamm 4(2):e322. https:\/\/doi.org\/10.1212\/NXI.0000000000000322","journal-title":"NeurolNeuroimmunolNeuroinflamm"},{"issue":"4","key":"10300_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/dmcn.13649","volume":"60","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Rossor T, Mankad K, Chong WK, Lux A, Wassmer E, Lim M, Barkhof F, Ciccarelli O, Hemingway C (2018) Leukodystrophy-like\u2019phenotype in children with MOG-antibody associated disease. Dev Med Child Neurol 60(4):417\u2013423. https:\/\/doi.org\/10.1111\/dmcn.13649","journal-title":"Dev Med Child Neurol"},{"key":"10300_CR15","doi-asserted-by":"publisher","first-page":"476960","DOI":"10.1016\/j.jneuroim.2019.05.001","volume":"333","author":"D Nagabushana","year":"2019","unstructured":"Nagabushana D, Shah R, Pendharkar H, Agrawal A, Kulkarni GB, Rajendran S, Alladi S, Mahadevan A (2019) MOG antibody seropositive aseptic meningitis: a new clinical phenotype. J Neuroimmunol 333:476960. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.05.001","journal-title":"J Neuroimmunol"},{"key":"10300_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-019-1525-1","volume":"16","author":"A Cobo-Calvo","year":"2019","unstructured":"Cobo-Calvo A, Sepulveda M, Rollot F, Armangue T, Ruiz A, Maillart E et al (2019) Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease. J Neuroinflammation 16:134. https:\/\/doi.org\/10.1186\/s12974-019-1525-1","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10300_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1352458519840747","volume":"26","author":"S Sundaram","year":"2019","unstructured":"Sundaram S, Nair SS, Jaganmohan D, Unnikrishnan G, Nair M (2019) Relapsing lumbosacral myeloradiculitis: an unusual presentation of MOG antibody disease. MultScler 26(4):509\u2013511. https:\/\/doi.org\/10.1177\/1352458519840747","journal-title":"MultScler"},{"key":"10300_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.msard.2019.01.032","volume":"30","author":"M Netravathi","year":"2019","unstructured":"Netravathi M, Bollampalli HK, Bhat MD, Ganaraja VH, Prasad S, Mahadevan A, Kamble N, Nalini A, Yadav R, Pal PK, Satishchandra P (2019) Clinical, neuroimaging and therapeutic response in AQP4-positive NMO patients from India. MultSclerRelatDisord 30:85\u201393. https:\/\/doi.org\/10.1016\/j.msard.2019.01.032","journal-title":"MultSclerRelatDisord"},{"issue":"6","key":"10300_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1352458516665497","volume":"23","author":"M Netravathi","year":"2017","unstructured":"Netravathi M, Saini J, Mahadevan A, Hari-Krishna B, Yadav R, Pal PK, Satishchandra P (2017) Is pruritus an indicator of aquaporin-positive neuromyelitis optica? MultScler 23(6):810\u2013817. https:\/\/doi.org\/10.1177\/1352458516665497","journal-title":"MultScler"},{"key":"10300_CR20","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.msard.2020.102399","volume":"45","author":"JR Ciotti","year":"2020","unstructured":"Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH (2020) Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. MultSclerRelatDisord 45:102399. https:\/\/doi.org\/10.1016\/j.msard.2020.102399","journal-title":"MultSclerRelatDisord"},{"key":"10300_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005560","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B et al (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000005560","journal-title":"Neurology"},{"key":"10300_CR22","doi-asserted-by":"publisher","first-page":"104319","DOI":"10.1016\/j.neuint.2018.10.016","volume":"130","author":"T Akaishi","year":"2019","unstructured":"Akaishi T, Sato DK, Takahashi T, Nakashima I (2019) Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein. Neurochem Int 130:104319. https:\/\/doi.org\/10.1016\/j.neuint.2018.10.016","journal-title":"Neurochem Int"},{"issue":"7","key":"10300_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1352458519845112","volume":"26","author":"De Mol","year":"2019","unstructured":"Mol De, Wong YYM, van Pelt ED, Wokke BHA, Siepman TAM, Neuteboom RF, Hamann D, Hintzen RQ (2019) The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. MultScler 26(7):806\u2013814. https:\/\/doi.org\/10.1177\/1352458519845112","journal-title":"MultScler"},{"key":"10300_CR24","doi-asserted-by":"publisher","first-page":"577143","DOI":"10.1016\/j.jneuroim.2019.577143","volume":"340","author":"R Pedapati","year":"2020","unstructured":"Pedapati R, Bhatia R, Singh N, Bali P, Gupta P, Saxena R, Dash D, Bhushansingh M, Padma Srivastava MV (2020) Anti-myelin oligodendrocyte glycoprotein antibody associated disease spectrum\u2014A north Indian tertiary care center experience and review of literature. J Neuroimmunol 340:577143. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577143","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10300_CR25","doi-asserted-by":"publisher","first-page":"205521731878782","DOI":"10.1177\/2055217318787829","volume":"4","author":"L Pandit","year":"2018","unstructured":"Pandit L, Mustafa S, Nakashima I, Takahashi T, Kaneko K (2018) MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response. MultScler J Exp Transl Clin 4(3):2055217318787829. https:\/\/doi.org\/10.1177\/2055217318787829","journal-title":"MultScler J Exp Transl Clin"},{"issue":"1","key":"10300_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ene.13790","volume":"26","author":"L Wang","year":"2019","unstructured":"Wang L, Zhangbao J, Zhou L, Zhang Y, Li H, Li Y et al (2019) Encephalitis is an important clinical component of MOG antibody associated demyelination: a single-centre cohort study in Shangai, China. Eur J Neurol 26(1):168\u2013174","journal-title":"Eur J Neurol"},{"key":"10300_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2018.12.003","volume":"328","author":"B Rojc","year":"2018","unstructured":"Rojc B, Podnar B, Graus F (2018) A case of recurrent MOG antibody positive bilateral ON and anti-NMDAR encephalitis: different biological evolution of the two associated antibodies. J Neuroimmunol 328:86\u201388","journal-title":"J Neuroimmunol"},{"key":"10300_CR28","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","volume":"266","author":"A Budhram","year":"2019","unstructured":"Budhram A, Mirian A, Le C, Hosseini\u00adMoghaddam SM, Sharma M, Nicolle MW (2019) Unilateral cortical FLAIR hyperintense Lesions in Anti\u00adMOG\u00adassociated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico\u00adradiographic syndrome. J Neurol 266:2481\u20132487","journal-title":"J Neurol"},{"key":"10300_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13791","volume":"26","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Jia X, Yang H, Chen C, Sun X, Peng L, Kermode AG, Qiu W (2019) Myelin oligodendrocyte glycoprotein antibody associated demyelination: comparison between onset phenotypes. Eur J Neurol 26:175\u2013183. https:\/\/doi.org\/10.1111\/ene.13791","journal-title":"Eur J Neurol"},{"key":"10300_CR30","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A et al (2017) Clinical presentation and prognosis in MOG\u00adantibody disease: a UK study. Brain 140:3128\u20133138. https:\/\/doi.org\/10.1093\/brain\/awx276","journal-title":"Brain"},{"key":"10300_CR31","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/brain\/awx276","volume":"267","author":"J Loos","year":"2020","unstructured":"Loos J, Pfeuffer S, Pape K, Ruck T, Luessi F, Spreer A et al (2020) MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation. J Neurol 267:1632\u20131642. https:\/\/doi.org\/10.1093\/brain\/awx276","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10300-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-10300-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10300-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T09:15:00Z","timestamp":1616577300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-10300-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10300"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10300-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"19 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any financial disclosure or Conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}